Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy

References

• Kastan MB, Schlaffer E, Russo JE, et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990; 75: 1947–50
   PubMed Web of Science ®Google Scholar
• Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 1999; 96: 9118–23
   PubMed Web of Science ®Google Scholar
• Jones RJ, Barber JP, Vala MS, et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995; 85: 2742–6
   PubMed Web of Science ®Google Scholar
• Fallon P, Gentry T, Balber AE, et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol 2003; 122: 99–108
   PubMed Web of Science ®Google Scholar
• Armstrong L, Stojkovic M, Dimmick I, et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on the basis of aldehyde dehydrogenase activity. Stem Cells 2004; 22: 1142–51
   PubMed Web of Science ®Google Scholar
• Jones RJ, Collector MI, Barber JP, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 1996; 88: 487–91
   PubMed Web of Science ®Google Scholar
• Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162–9
   PubMed Web of Science ®Google Scholar
• Storms RW, Green PD, Safford KM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005; 106: 95–102
   PubMed Web of Science ®Google Scholar
• Hess DA, Meyerrose TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 1648–55
   PubMed Web of Science ®Google Scholar
• Lioznov MV, Freiberger P, Kroger N, et al. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 35: 909–14
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24: 975–85
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Papadimitriou D, et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006; 15: 167–87
   PubMed Web of Science ®Google Scholar
• Cai J, Cheng A, Luo Y, et al. Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem 2004; 88: 212–26
   Google Scholar
• Laird DJ, De Tomaso AW, Weissman IL. Stem cells are units of natural selection in a colonial ascidian. Cell 2005; 123: 1351–60
   PubMed Web of Science ®Google Scholar
• Cai J, Weiss ML, Rao MS. In search of ‘stemness’. Exp Hematol 2004; 32: 585–598
   PubMed Web of Science ®Google Scholar
• Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006; 66: 606–30
   PubMedGoogle Scholar
• Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 11707–12
   PubMed Web of Science ®Google Scholar
• Kucia M, Reca R, Jala VR, et al. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 2005; 19: 1118–27
   PubMed Web of Science ®Google Scholar
• Briguori C, Reimers B, Sarais C, et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006; 151: 674–80
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199–209
   PubMed Web of Science ®Google Scholar
• Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287–94
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Honold J, et al. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol 2006; 95: 13–22
   Google Scholar
• Schaefer A, Meyer GP, Fuchs M, et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006; 27: 929–35
   PubMed Web of Science ®Google Scholar
• Tse HF, Thambar S, Kwong YL, et al. Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 2006; 98: 60–2
   PubMedGoogle Scholar
• Rosenzweig A. Cardiac cell therapy: mixed results from mixed cells. N Engl J Med 2006; 355: 1274–7
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141–8
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004; 110: II213–18
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294–302
   PubMed Web of Science ®Google Scholar
• Hamano K, Nishida M, Hirata K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001; 65: 845–7
   PubMedGoogle Scholar
• Fukuda S, Yoshii S, Kaga S, et al. Angiogenic strategy for human ischemic heart disease: brief overview. Mol Cell Biochem 2004; 264: 143–9
   Google Scholar
• Durdu S, Akar AR, Arat M , et al. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II–III thromboangiitis obliterans. J Vasc Surg 2006;44:732–9.
   PubMedGoogle Scholar
• Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol 2005; 63: 351–60
   PubMedGoogle Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427–35
   PubMed Web of Science ®Google Scholar
• Kim D-I, Kim M-J, Joh J-H , et al. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells 2006;24:1194–1200.
   PubMed Web of Science ®Google Scholar
• Giliani S, Mori L, de Saint Basile G, et al. Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 2005; 203: 110–26
   PubMed Web of Science ®Google Scholar
• Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005; 56: 79–101
   PubMed Web of Science ®Google Scholar
• Gulati R, Jevremovic D, Peterson TE, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003; 93: 1023–5
   PubMed Web of Science ®Google Scholar
• Mahmoud MI, Potter JJ, Colvin OM, et al. Effect of 4-(diethylamino)benzaldehyde on ethanol metabolism in mice. Alcohol Clin Exp Res 1993; 17: 1223–7
   Google Scholar
• Novelli EM, Ramirez M, Civin CI. Biology of CD34+. Leuk Lymphoma 1998; 31: 285–93
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002–12
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952–8
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343–53
   PubMed Web of Science ®Google Scholar
• Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106–12
   PubMed Web of Science ®Google Scholar
• Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337–46
   PubMed Web of Science ®Google Scholar
• Belicchi M, Pisati F, Lopa R, et al. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 2004; 77: 475–86
   PubMed Web of Science ®Google Scholar
• Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97: 14720–5
   PubMed Web of Science ®Google Scholar
• Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54–63
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Stewart K, Monk P, Walsh S, et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res 2003; 313: 281–90
   PubMed Web of Science ®Google Scholar
• Weekx SF, Snoeck HW, Offner F, et al. Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alpha. Blood 2000; 95: 2806–12
   Google Scholar
• Ohneda O, Ohneda K, Arai F, et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 2001; 98: 2134–42
   PubMed Web of Science ®Google Scholar
• Sutherland HJ, Eaves CJ, Eaves AC, et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563–70
   PubMed Web of Science ®Google Scholar
• Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci USA 2002; 99: 413–18
   PubMed Web of Science ®Google Scholar
• Mancuso P, Burlini A, Pruneri G, et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 3658–61
   PubMed Web of Science ®Google Scholar
• Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331–42
   PubMed Web of Science ®Google Scholar
• Medina KL, Singh H. Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol 2005; 12: 203–9
   Google Scholar
• Pierelli L, Bonanno G, Rutella S, et al. CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma 2001; 42: 1195–206
   PubMed Web of Science ®Google Scholar
• Pierelli L, Scambia G, Bonanno G, et al. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/− precursors. Br J Haematol 2000; 108: 610–20
   PubMed Web of Science ®Google Scholar
• Begemann PG, Hassan HT, Kroger N, et al. Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation. J Hematother Stem Cell Res 2002; 11: 321–6
   PubMedGoogle Scholar
• Charrier S, Boiret N, Fouassier M, et al. Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro. Exp Hematol 2002; 30: 1051–60
   PubMedGoogle Scholar
• Murray LJ, Mandich D, Bruno E, et al. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Exp Hematol 1996; 24: 236–45
   Google Scholar
• Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24: 376–85
   PubMed Web of Science ®Google Scholar
• Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999; 265: 134–9
   PubMed Web of Science ®Google Scholar
• Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875–84
   PubMed Web of Science ®Google Scholar
• Owen M. Marrow stromal stem cells. J Cell Sci Suppl 1988; 10: 63–76
   PubMedGoogle Scholar
• Bhatia M, Bonnet D, Murdoch B, et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038–45
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Meida-Porada G, Livingston AG, et al. Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998; 26: 353–60
   PubMed Web of Science ®Google Scholar
• Gallacher L, Murdoch B, Wu DM, et al. Isolation and characterization of human CD34(–)Lin(–) and CD34(+)Lin(–) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813–20
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Ratajczak J, Kuczynski W, et al. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Exp Hematol 1993; 21: 1663–7
   Google Scholar
• Capoccia BJ, Wirthlin L, Shepherd R, et al. Bone marrow-derived aldehyde dehydrogenase expressing cells possess endothelial progenitor function in addition to hematopoietic repopulating ability and aid in blood flow recovery after acute ischemic injury. Blood 2005; 106: 2663
   Google Scholar
• Estes BT, Wu AW, Storms RW, Guilak F. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol 2006; 209: 987–95
   PubMed Web of Science ®Google Scholar
• Aslan H, Zilberman Y, Kendel A, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006; 24: 1728–37
   PubMed Web of Science ®Google Scholar
• Ito A, Hibino E, Shimizu K, et al. Magnetic force-based mesenchymal stem cell expansion using antibody-conjugated magnetoliposomes. J Biomed Mater Res B Appl Biomater 2005; 75: 320–7
   Google Scholar